Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hüller

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Die Pharmazie|November 1, 1985
[Quantitative determination and kinetics of dihydralazine in hypertension patients]W Siegmund, M Zschiesche, R Kallwellis, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Effect of methotrexate on the pharmacokinetics and renal excretion of cisplatinR Preiss, V K Brovtsyn, N I Perevodchikova, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1985
The influence of the acetylator phenotype for the clinical use of dihydralazineW Siegmund, G Franke, K E Biebler, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Die Pharmazie|November 1, 1985
[Quantitative determination and kinetics of dihydralazine in hypertension patients]W Siegmund, M Zschiesche, R Kallwellis, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Effect of methotrexate on the pharmacokinetics and renal excretion of cisplatinR Preiss, V K Brovtsyn, N I Perevodchikova, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1985
The influence of the acetylator phenotype for the clinical use of dihydralazineW Siegmund, G Franke, K E Biebler, et al.
Pageof 5